Improving Colorectal Cancer Screening Uptake Through Education and Stool-Based Testing Outreach

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-75
SponsorWashington University School of Medicine

About this trial

This is a mixed-methods implementation pilot combining an educational intervention with a mailed stool-based testing outreach feasibility study within a resident primary care clinic. Participants will be assigned by clinic team to education, mailed FIT, mailed Cologuard, or usual care comparison groups.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Previously enrolled in prior study IRB #202202059 who agreed to participate in future research

Disqualifiers

Not enrolled in prior study IRB #202202059

Primary Care Medicine Clinic patient (PRMC)

Eligible for CRC screening

Between age 45-75 years old

Trial design

Design model

Parallel

Treatments tested in this trial

  • Colorectal Cancer Education Materials

    Behavioral

    Education materials are compiled from the American College of Gastroenterology (ACG) and the City of Hope. The education materials are at a 6th grade reading level. Materials detail digestive system and polyp background, colorectal cancer (CRC) risk factors, warning signs, screening options, recommended initial screening age, and stool-based screening and colonoscopy processes.

  • Cologuard test kit

    Diagnostic test

    The Cologuard test will be mailed to the participants. Participants will complete the test via the step-by-step written and pictorial instructions provided and mail the complete test with the pre-paid return label provided.

  • Fecal immunochemical test kit

    Diagnostic test

    The Fecal immunochemical test (FIT) will be mailed to the participants. Participants will complete the test via the step-by-step written and pictorial instructions provided and mail the complete test with the pre-paid return label provided.

  • Usual Care

    Behavioral

    Usual care for patients eligible for colorectal cancer screening will be provided by the Barnes-Jewish Hospital Primary Care Medicine Clinic.

Treatment groups

200 Participants
are divided into 4 treatment groups
Group A: EducationExperimental treatment 1 intervention
Group B: Mailed FITExperimental treatment 1 intervention
Group C: Mailed CologuardExperimental treatment 1 intervention
Group D: Usual CareActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in CRC knowledge (Education Arm only)

Change in CRC knowledge will be measured by changes in the score of the Assessment of Colon Cancer Literacy (ACCL) test. The ACCL consists of 10-items with True/False/Unsure. The ACCL score ranges from 0 to 10 with a score of 7-10 indicating adequate literacy and scores of 0-6 indicating limited literacy.

Time frame
At enrollment and 3 months after educational intervention (total estimated time is 3 months)
2

Feasibility as measured by the percentage of kits returned (Mailed FIT and Mailed Cologuard Arms only)

Time frame
At 3 months after receiving kit (total estimated time 3 months)
3

Acceptability of stool based testing (Mailed FIT and Mailed Cologuard Arms only)

Acceptability will be assessed using the 3-item Customer Service Questionnaire (CSQ-3). The 3-items are rated on a 4-point Likert scale as follows: 1=Poor, 2=Fair, 3=Good, and 4=Excellent. Generally, the higher the score indicates greater customer satisfaction.

Time frame
At completion of testing or at 3 months after receiving test kit (total estimated time 3 months)
4

CRC screening completion rate (All arms)

CRC screening completion rate will be assessed through electronic health record (EHR) verification of screening completion.

Time frame
From time of receiving CRC kit to 6 months after receiving kit (total estimated time 6 months)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: